BioNova Pharma

About BioNova Pharma

BioNova Pharma develops biopharmaceutical treatments targeting cancer through advanced drug formulation and delivery methods. The company focuses on addressing the unmet medical needs of patients with various cancer types by enhancing therapeutic efficacy and minimizing side effects.

```xml <problem> Many cancer treatments face challenges in effectively targeting tumor cells while minimizing damage to healthy tissues, leading to significant side effects and reduced therapeutic efficacy. Traditional drug formulations may also have limited bioavailability, hindering their ability to reach the tumor site in sufficient concentrations. </problem> <solution> BioNova Pharma develops biopharmaceutical treatments for cancer using advanced drug formulation and targeted delivery methods. The company focuses on enhancing therapeutic efficacy and reducing side effects by improving drug bioavailability and selectively targeting cancer cells. Their approach aims to address the unmet medical needs of patients with various cancer types through innovative pharmaceutical solutions. </solution> <features> - Pipeline of novel drug candidates (BN104, BN105) targeting various cancer types. - Advanced drug formulation techniques to improve bioavailability and stability. - Targeted drug delivery systems designed to selectively deliver therapeutic agents to tumor cells. - Focus on minimizing off-target effects and reducing treatment-related toxicities. </features> <target_audience> The primary target audience includes patients with various cancer types, oncologists, and healthcare providers seeking more effective and less toxic treatment options. </target_audience> ```

What does BioNova Pharma do?

BioNova Pharma develops biopharmaceutical treatments targeting cancer through advanced drug formulation and delivery methods. The company focuses on addressing the unmet medical needs of patients with various cancer types by enhancing therapeutic efficacy and minimizing side effects.

Where is BioNova Pharma located?

BioNova Pharma is based in Shanghai, China.

When was BioNova Pharma founded?

BioNova Pharma was founded in 2018.

How much funding has BioNova Pharma raised?

BioNova Pharma has raised 25000000.

Location
Shanghai, China
Founded
2018
Funding
25000000
Employees
14 employees
Major Investors
Hanne Capital

Find Investable Startups and Competitors

Search thousands of startups using natural language

BioNova Pharma

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

BioNova Pharma develops biopharmaceutical treatments targeting cancer through advanced drug formulation and delivery methods. The company focuses on addressing the unmet medical needs of patients with various cancer types by enhancing therapeutic efficacy and minimizing side effects.

bionovapharma.com300+
cb
Crunchbase
Founded 2018Shanghai, China

Funding

$

Estimated Funding

$20M+

Major Investors

Hanne Capital

Team (10+)

No team information available.

Company Description

Problem

Many cancer treatments face challenges in effectively targeting tumor cells while minimizing damage to healthy tissues, leading to significant side effects and reduced therapeutic efficacy. Traditional drug formulations may also have limited bioavailability, hindering their ability to reach the tumor site in sufficient concentrations.

Solution

BioNova Pharma develops biopharmaceutical treatments for cancer using advanced drug formulation and targeted delivery methods. The company focuses on enhancing therapeutic efficacy and reducing side effects by improving drug bioavailability and selectively targeting cancer cells. Their approach aims to address the unmet medical needs of patients with various cancer types through innovative pharmaceutical solutions.

Features

Pipeline of novel drug candidates (BN104, BN105) targeting various cancer types.

Advanced drug formulation techniques to improve bioavailability and stability.

Targeted drug delivery systems designed to selectively deliver therapeutic agents to tumor cells.

Focus on minimizing off-target effects and reducing treatment-related toxicities.

Target Audience

The primary target audience includes patients with various cancer types, oncologists, and healthcare providers seeking more effective and less toxic treatment options.

Want to add first party data to your startup here or get your entry removed? You can edit it yourself by logging in with your company domain.